[Skip to Content]
[Skip to Content Landing]
Article
July 1982

Leukoplasmapheresis for Myasthenia GravisAcetylcholine Receptor Antibody Production

Author Affiliations

From the Veterans Administration Medical Center and University of California, San Diego (Dr Seybold); Scripps Clinic and Research Foundation, La Jolla, Calif (Drs Tsoukas, Fong, and Vaughan); and Salk Institute for Biological Studies, San Diego (Dr Lindstrom).

Arch Neurol. 1982;39(7):433-435. doi:10.1001/archneur.1982.00510190051016
Abstract

• Acetylcholine receptor antibody (AChR-ab) and IgG were studied in vivo and in vitro in a patient with myasthenia gravis, who was undergoing multiple leukoplasmaphereses. In this patient, leukoplasmapheresis accelerated production of AChR-ab and total IgG as would be expected if antibody acted through feedback as an inhibitor of its own synthesis. Cells capable of suppressing AChR-ab production were demonstrated before and after leukoplasmapheresis, indicating that AChR-ab production in this patient was not the result of detectable loss of suppressor-cell activity.

×